ACKC is a grassroots organization established in 2003 by kidney cancer patients and their families/caregivers who are working to raise awareness of kidney cancer and to ensure that it receives the public and private funding required to identify and develop effective treatment modalities and to find a cure for this disease. More >

Blog

  • Jackson Pollack Barf, Michael Jackson Juice and My First Post Sutent CT Scan

    November 12th, 2011 Chris Battle, survivor

    Well into the second cycle of Sutent, I’m still at full dosage despite my oncologist’s fear that I would not be able to handle that level of toxicity. You may recall that I take Sutent for four weeks, and the side effects build over the course of that period, then I take a two-week break [...]

  • Sutent, Round 1: Dental Harpies, Wood Glue and Forrest Gump

    October 15th, 2011 Chris Battle, survivor

    There’s something to be said for maintaining control over your body, even if that means abusing it a little.

  • Why Put Off Sutent?

    September 20th, 2011 Chris Battle, survivor

    Some have asked: Why did you put off Sutent for so long? Well, first, because one of the warnings that came with the drug was that it can cause dizziness, which will be made worse if taken with alcohol. And, really, who wants to go on a drug that can’t be taken with alcohol? Second, our oncologist put it: There are only so many tools in the toolbox to fight kidney cancer, and we should try to use them all. It’s a question of sequencing.

See All

News

  • Dr. Janice Dutcher Moves Offices Dr. Janice Dutcher has moved her clinical practice and IL-2 treatment program from the Montefiore Medical Center in the Bronx to the St. Luke’s Roosevelt Hospital Center in Manhattan where Dr. Dutcher is the Director of the Immunotherapy Program. More >

  • Stanford University Researchers Identify Kidney Cancer Killer Stanford University researchers have discovered a molecule that directly attacks kidney cancer cells that have the VHL tumor-suppressor gene mutated or disabled. VHL deficient genes are present in 85-90% of clear cell carcinoma, the most prevalent type of kidney cancer. More >

Events